Denis Delebassée

583 total citations
9 papers, 457 citations indexed

About

Denis Delebassée is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Denis Delebassée has authored 9 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Surgery. Recurrent topics in Denis Delebassée's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Leech Biology and Applications (2 papers) and Venomous Animal Envenomation and Studies (2 papers). Denis Delebassée is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Leech Biology and Applications (2 papers) and Venomous Animal Envenomation and Studies (2 papers). Denis Delebassée collaborates with scholars based in France and United Kingdom. Denis Delebassée's co-authors include G. Defreyn, J.P. Maffrand, A. Bernat, Jean‐Pierre Maffrand, Pierre Savi, Jean‐Marc Herbert, F. Dol, Jean Combalbert, Jean‐Pierre Cazenave and John L. Gordon and has published in prestigious journals such as Biochemical Pharmacology, European Journal of Medicinal Chemistry and Thrombosis and Haemostasis.

In The Last Decade

Denis Delebassée

9 papers receiving 433 citations

Peers

Denis Delebassée
E. Vallée France
JM Herbert France
Earl J. Crain United States
M A Orchard United Kingdom
E. Vallée France
Denis Delebassée
Citations per year, relative to Denis Delebassée Denis Delebassée (= 1×) peers E. Vallée

Countries citing papers authored by Denis Delebassée

Since Specialization
Citations

This map shows the geographic impact of Denis Delebassée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Delebassée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Delebassée more than expected).

Fields of papers citing papers by Denis Delebassée

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Delebassée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Delebassée. The network helps show where Denis Delebassée may publish in the future.

Co-authorship network of co-authors of Denis Delebassée

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Delebassée. A scholar is included among the top collaborators of Denis Delebassée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Delebassée. Denis Delebassée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Savi, Pierre, Jean‐Marc Herbert, F. Dol, et al.. (1992). Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel. Biochemical Pharmacology. 44(3). 527–532. 161 indexed citations
2.
Laurens, Claire, Jacqueline Fournier, Denis Delebassée, et al.. (1991). Enhancement of neurite outgrowth from central nervous system neurons in primary culture by thrombin inhibitors. Neuroscience Letters. 124(1). 1–4. 5 indexed citations
3.
Maffrand, J.P., J. M. Herbert, A. Bernat, et al.. (1991). Experimental and clinical pharmacology of pentosan polysulfate.. PubMed. 17 Suppl 2. 186–98. 33 indexed citations
4.
Freund, Monique, Jean‐Pierre Cazenave, Michael Courtney, et al.. (1990). Inhibition by Recombinant Hirudins of Experimental Venous Thrombosis and Disseminated Intravascular Coagulation Induced by Tissue Factor in Rats. Thrombosis and Haemostasis. 63(2). 187–192. 40 indexed citations
5.
Courtney, Michael, G. Loison, Yves Lemoine, et al.. (1989). Production and Evaluation of Recombinant Hirudin. Seminars in Thrombosis and Hemostasis. 15(3). 288–292. 15 indexed citations
6.
Bernat, A., et al.. (1989). Pharmacology of Ticlopidine: A Review. Seminars in Thrombosis and Hemostasis. 15(2). 159–166. 61 indexed citations
7.
Etemad‐Moghadam, Guita, Denis Delebassée, Jean‐Pierre Maffrand, & D. FREHEL. (1988). Syntheses of Nα-(β-naphthylsulfonylaminoglycyl)-argininamides as potential selective synthetic thrombin inhibitors. European Journal of Medicinal Chemistry. 23(6). 577–585. 2 indexed citations
8.
Maffrand, J.P., A. Bernat, Denis Delebassée, et al.. (1988). ADP Plays a Key Role in Thrombogenesis in Rats. Thrombosis and Haemostasis. 59(2). 225–230. 75 indexed citations
9.
Delebassée, Denis, Michel Simon, Hugues Chap, et al.. (1987). Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Thrombosis Research. 48(4). 403–415. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026